drugset / Trial / NCT01593644
Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler
NaSingle-groupSingle-blind
Summary
The purpose of this study is to evaluate the efficacy and tolerance of a dipyridamole/adenosine combination given intravenously, as a slow bolus and at low doses to adenosine alone (given at its recommended dosage adjusted to patients' weight) for coronary flow reserve assessment (in 60-75 patients with stable ischemic heart disease) using transthoracic echodoppler
Timeline
- Start
- 2011-06
- Primary completion
- 2013-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adenosine | Small molecule | 6 mg | Intravenous |
| Subject | Dipyridamole | Other / unclassified | 10 mg | Intravenous |